— Know what they know.
Not Investment Advice

MYMX OTC

Mymetics Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $46 mcap · 73585 float · 0.0014% daily turnover

Balance Sheet Trends

Total Assets
$7M -4.1% ▼
5Y CAGR: -1.9%
Total Liabilities
$72M +6.6% ▲
5Y CAGR: +7.2%
Shareholders Equity
-$65M -8.0% ▼
Cash & Investments
$313K -45.2% ▼
5Y CAGR: -23.3%
Total Debt
$72M +6.4% ▲
5Y CAGR: +7.4%
Net Debt
$72M +6.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$479K$683K$1M$571K$313K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$479K$683K$1M$571K$313K
Net Receivables$585K$154K$71K$15K$62K
Inventory$0$0$0$0$0
Other Current Assets$0$10K$0$0$0
Total Current Assets$1M$932K$1M$673K$481K
Property, Plant & Equip.$36K$79K$176K$278K$159K
Goodwill & Intangibles$7M$7M$7M$7M$7M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$10K$10K$10K
Total Non-Current Assets$7M$7M$7M$7M$7M
Total Assets$8M$8M$8M$8M$7M
— Liabilities —
Accounts Payable$75K$167K$70K$47K$213K
Short-Term Debt$55M$59M$63M$67M$72M
Deferred Revenue$0-$102K$0-$110K$7K
Other Current Liabilities$0$0$0$110K$0
Total Current Liabilities$55M$59M$63M$67M$72M
Long-Term Debt$0$0$156K$162K$156K
Other Non-Current Liab.$0-$101K$0$0$0
Total Non-Current Liabilities$55M$27K$183K$292K$187K
Total Liabilities$55M$59M$63M$68M$72M
— Equity —
Common Stock$3M$3M$3M$3M$3M
Retained Earnings-$85M-$89M-$93M-$98M-$103M
Accumulated OCI$679K$691K$695K$691K$686K
Total Stockholders Equity-$47M-$51M-$55M-$60M-$65M
Total Liabilities & Equity$8M$8M$8M$8M$7M
— Key Metrics —
Total Debt$55M$59M$63M$68M$72M
Net Debt$54M$58M$62M$67M$72M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms